{"id":"https://openalex.org/W2003804085","doi":"https://doi.org/10.1016/s0165-6147(99)01320-6","title":"Chimaeric G\u03b1 proteins: their potential use in drug discovery","display_name":"Chimaeric G\u03b1 proteins: their potential use in drug discovery","alternate_titles":[],"publication_year":1999,"publication_date":"1999-03-01","ids":{"openalex":"https://openalex.org/W2003804085","doi":"https://doi.org/10.1016/s0165-6147(99)01320-6","mag":"2003804085","pmid":"https://pubmed.ncbi.nlm.nih.gov/10203868"},"language":"en","primary_location":{"id":"doi:10.1016/s0165-6147(99)01320-6","doi":"https://doi.org/10.1016/s0165-6147(99)01320-6","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0165-6147(99)01320-6","pdf_url":null,"source":{"id":"https://openalex.org/S31167473","display_name":"Trends in Pharmacological Sciences","issn_l":"0165-6147","issn":["0165-6147","1873-3735"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Trends in Pharmacological Sciences","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2003804085"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051585961","display_name":"Graeme Milligan","orcid":"https://orcid.org/0000-0002-6946-3519","observed_orcids":["https://orcid.org/0000-0002-6946-3519"]},"institutions":[{"id":"https://openalex.org/I7882870","display_name":"University of Glasgow","ror":"https://ror.org/00vtgdb53","country_code":"GB","type":"education","lineage":["https://openalex.org/I7882870"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Graeme Milligan","raw_affiliation_strings":["University of Glasgow, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Glasgow, UK","institution_ids":["https://openalex.org/I7882870"]}]},{"author_position":"last","author":{"id":null,"display_name":"Stephen Rees","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Stephen Rees","raw_affiliation_strings":["Receptor Systems Unit, Glaxo-Wellcome Research and Development, Stevenage, UK SG1 2NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Receptor Systems Unit, Glaxo-Wellcome Research and Development, Stevenage, UK SG1 2NY","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":7030,"currency":"USD","value_usd":7030},"apc_paid":null,"fwci":0.5932,"has_fulltext":false,"cited_by_count":95,"citation_normalized_percentile":{"value":0.53366697,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":96},"biblio":{"volume":"20","issue":"3","first_page":"118","last_page":"124"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/g-protein-alpha-subunit","display_name":"G protein alpha subunit","score":0.8709999918937683},{"id":"https://openalex.org/keywords/g-protein-coupled-receptors","display_name":"G protein-coupled receptors","score":0.9929999709129333},{"id":"https://openalex.org/keywords/high-throughput-screening","display_name":"high-throughput screening","score":0.878000020980835},{"id":"https://openalex.org/keywords/receptor-effector-interaction","display_name":"receptor-effector interaction","score":0.6600000262260437},{"id":"https://openalex.org/keywords/gpcr-pharmacology","display_name":"GPCR pharmacology","score":0.4970000088214874},{"id":"https://openalex.org/keywords/drug-discovery","display_name":"drug discovery","score":0.7879999876022339}],"concepts":[{"id":"https://openalex.org/C135285700","wikidata":"https://www.wikidata.org/wiki/Q38173","display_name":"G protein-coupled receptor","level":3,"score":0.7827713489532471},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.7460044026374817},{"id":"https://openalex.org/C51785407","wikidata":"https://www.wikidata.org/wiki/Q2627568","display_name":"Effector","level":2,"score":0.715610146522522},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.6627574563026428},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.5946990251541138},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5852594971656799},{"id":"https://openalex.org/C51323132","wikidata":"https://www.wikidata.org/wiki/Q626251","display_name":"High-throughput screening","level":2,"score":0.5383127927780151},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4186825156211853},{"id":"https://openalex.org/C116569031","wikidata":"https://www.wikidata.org/wiki/Q899107","display_name":"Ligand (biochemistry)","level":3,"score":0.4155493378639221},{"id":"https://openalex.org/C147816474","wikidata":"https://www.wikidata.org/wiki/Q169525","display_name":"Protein engineering","level":3,"score":0.41370153427124023},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.28932011127471924},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.2846164107322693},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2575421929359436},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.15573564171791077},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D013678","descriptor_name":"Technology, Pharmaceutical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D019204","descriptor_name":"GTP-Binding Proteins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/s0165-6147(99)01320-6","doi":"https://doi.org/10.1016/s0165-6147(99)01320-6","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0165-6147(99)01320-6","pdf_url":null,"source":{"id":"https://openalex.org/S31167473","display_name":"Trends in Pharmacological Sciences","issn_l":"0165-6147","issn":["0165-6147","1873-3735"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Trends in Pharmacological Sciences","raw_type":"journal-article"},{"id":"pmid:10203868","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10203868","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Trends in pharmacological sciences","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320311904","display_name":"Wellcome Trust","ror":"https://ror.org/029chgv08"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":43,"referenced_works":["https://openalex.org/W168456839","https://openalex.org/W1177666862","https://openalex.org/W1482828226","https://openalex.org/W1531545561","https://openalex.org/W1546486342","https://openalex.org/W1603345835","https://openalex.org/W1793371190","https://openalex.org/W1878156379","https://openalex.org/W1966960186","https://openalex.org/W1972847099","https://openalex.org/W1976310120","https://openalex.org/W1980058356","https://openalex.org/W1984212762","https://openalex.org/W1988018358","https://openalex.org/W1992639113","https://openalex.org/W2001289439","https://openalex.org/W2001402428","https://openalex.org/W2002915668","https://openalex.org/W2013968961","https://openalex.org/W2017821806","https://openalex.org/W2023623309","https://openalex.org/W2025818505","https://openalex.org/W2027234006","https://openalex.org/W2029611470","https://openalex.org/W2036386823","https://openalex.org/W2041208984","https://openalex.org/W2046378079","https://openalex.org/W2066109743","https://openalex.org/W2067861784","https://openalex.org/W2068549941","https://openalex.org/W2069310788","https://openalex.org/W2070584259","https://openalex.org/W2073230423","https://openalex.org/W2111339077","https://openalex.org/W2114460420","https://openalex.org/W2151786024","https://openalex.org/W2168808956","https://openalex.org/W2289623110","https://openalex.org/W2325795238","https://openalex.org/W2412242336","https://openalex.org/W4233214449","https://openalex.org/W4248350370","https://openalex.org/W4302341872"],"related_works":["https://openalex.org/W1994086577","https://openalex.org/W2092327513","https://openalex.org/W1817884798","https://openalex.org/W2100132507","https://openalex.org/W2736717172","https://openalex.org/W2138683494","https://openalex.org/W1975074970","https://openalex.org/W2098544846","https://openalex.org/W2474485417","https://openalex.org/W2049103849"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2003804085","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
